//
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Comparative analysis of recurrent events after presentation with an index myocardial infarction or ischaemic stroke
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design